Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

UK life sciences investor Syncona is bankrolling a new gene therapy company, Beacon Therapeutics, that emerged this morning with a pipeline headed by a therapy acquired from US biotech AGTC last year.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

The team behind this fund hasn’t made its concentrated approach work. Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most ...

Roofing and building products distributor Beacon announced Nov. 1 its acquisition of Jacksonville, Florida-based Coastal Construction Products from distribution-focused private equity firm Supply ...

After publicly trading barbs for four months, QXO and Beacon Roofing Supply have come to terms. Citing company executives, the Wall Street Journal reported late Wednesday night that QXO has inked a ...

State Key Joint Laboratory of Environment Simulation and Pollution Control, School of Environment, Tsinghua University, Beijing 100084, China Institute for Integrated Catalysis, Pacific Northwest ...

--logo-padding "" Sets the padding left and right of the logo --logo-padding-left 0 Sets the padding to the left of the logo --logo-padding-right 4 Sets the padding to the right of the logo ...

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...

Copyright © 2025 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...